TrialRheumatology (Oxford, England)2024

Effect of bimekizumab on patient-reported disease impact in patients with psoriatic arthritis: 1-year results from two phase 3 studies.

Laure Gossec et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.